Newsletter / Paid-only AstraZeneca vaccine: a regulatory test; The new ACT-A strategy By Priti Patnaik / 16 Mar 2021
Newsletter / Paid-only Could Vaccine Nationalism Spur Disputes At The WTO; TRIPS Waiver Talks Update By Priti Patnaik / 12 Mar 2021
Newsletter / Paid-only The concerted push to address vaccine production shortages By Priti Patnaik / 9 Mar 2021
Newsletter / Paid-only The COVAX Allocation Algorithm for Vaccine Distribution By Priti Patnaik / 5 Mar 2021
Newsletter / Paid-only Vaccine Passports; Geneva Health Files goes paid! By Priti Patnaik / 2 Mar 2021
Newsletter / Paid-only "The Third Way": A key to unlock TRIPS Waiver negotiations? By Priti Patnaik / 26 Feb 2021
Newsletter / Paid-only Making Investigative Global Health Journalism Possible By Priti Patnaik / 24 Feb 2021
Newsletter / Paid-only Limits to vaccine diplomacy; TRIPS Waiver discussions deadlocked By Priti Patnaik / 23 Feb 2021
Newsletter / Paid-only Constraints facing the COVID-19 Technology Access Pool (C-TAP) By Priti Patnaik / 19 Feb 2021
Newsletter / Paid-only Geneva's trailblazing week: Ngozi Okonjo-Iweala "fresh eyes" at WTO By Priti Patnaik / 16 Feb 2021
Newsletter / Paid-only The ACT-A Agenda: The financialization of a pandemic? By Priti Patnaik / 12 Feb 2021
